NEUROPATH
Curator
1 mandateCurator, Rue De La Halle, 20, 7860 Lessines
from 12-03-2024 to 17-03-2026
Also on 153 other cases
Last board
4 directors, last change in 2023Manager
appointed by deed of 11-10-2019
term without a fixed end
listed in the 2022 annual accounts, filed on 06-01-2023
Creabbatical
Director, permanent representative TAS Benoit Yvonne
appointed by deed of 06-12-2019
listed in the 2022 annual accounts, filed on 06-01-2023
Director (not named in the articles)
appointed by deed of 29-09-2023
also on the board of 1 other company
Manager, permanent representative VERMEULEN Stijn
appointed by deed of 11-10-2019
term without a fixed end
earlier director, until 29-09-2023
also on the board of 3 other companies
listed in the 2022 annual accounts, filed on 06-01-2023
Permanent representatives 2
Mandates through the years
7 names, the dashed line is todayC.P.M. STRATEGY
Manager
Manager
TIBOR Luka
Manager (not named in the articles)
Manager (not named in the articles)
Creabbatical
Director
Director
DUPONT Vincent Joseph Henri
Director (not named in the articles)
Director (not named in the articles)
VAN HOUTTE Paul
Manager (not named in the articles)
Manager (not named in the articles)
Levantas
Director
Director
Liemaqs BVBA
Manager (not named in the articles)
Manager (not named in the articles)
BoardEarliermandate already running before its first mentionend not datedBankruptcy 12-03-2024
Mandates as a list
- C.P.M. STRATEGY
- Manager (not named in the articles), appointed by deed of 11-10-2019, until 29-09-2023
- Manager, appointed by deed of 11-10-2019, until the bankruptcy of 12-03-2024
- TIBOR Luka
- Manager (not named in the articles), appointed by deed of 11-10-2019, until the bankruptcy of 12-03-2024
- Creabbatical
- Director, appointed by deed of 06-12-2019, until the bankruptcy of 12-03-2024
- DUPONT Vincent Joseph Henri
- Director (not named in the articles), appointed by deed of 29-09-2023, until the bankruptcy of 12-03-2024
- VAN HOUTTE Paul
- Manager (not named in the articles), appointed by deed of 11-10-2019, until 29-09-2023
- Levantas
- Director, until 06-12-2019
- Director, until 06-12-2019
- Liemaqs BVBA
- Manager (not named in the articles), appointed by deed of 11-10-2019, no longer listed in the 2022 annual accounts
Control
Shareholders
TAS Benoit, LOUAGIE Jan, LUKA Daniel
and 6 others
This company
NEUROPATH
Equity €3,313
Loss €499,273 in 2022
Capital
- Capital
- €763,330.23
- Shares
- 64,494 in the deed of 22-06-2018 and 7 later capital increases
- Contribution per share
- €11.84
- Equity per share
- €0.05 in 2022
- Source
- deed of 06-12-2019 and 1 later capital increase
Owners through the years
as the annual accounts name themOwners as a list
- WAPI 2020
Source: lists of holdings in the owners' accounts
Articles of association
deed of 11-10-2019 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Thursday of December at 10:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Algemene vergadering, alle machten in artikel 2:87 WVV zonder bijzondere machtiging”
Shareholders
After the capital increase
deed of 29-09-2023 ↗
- TAS Benoit 166 shares
- LOUAGIE Jan 158 shares
- LUKA Daniel 79 shares
- VERMEULEN Stijn 197 shares
- VAN HOUTTE Paul 79 shares
- VERSCHELDEN 395 shares
- PROFUNDUS 752 shares
- GENAXIS 391 shares
- DONNELLY Kevin 158 shares
Stated in the deed
deed of 29-09-2023 ↗
- TAS Benoit 166 shares
- LOUAGIE Jan 158 shares
- LUKA Daniel 79 shares
- VERMEULEN Stijn 197 shares
- VAN HOUTTE Paul 79 shares
- VERSCHELDEN 395 shares
- PROFUNDUS 752 shares
- GENAXIS 391 shares
- DONNELLY Kevin 158 shares
Capital transactions
Capital over time
- 29-09-2023 Capital increase of €347,230.80 · 2,375 new shares · in kind
- 06-12-2019 Capital increase of €78,500 · to €416,099.43 · 1,010 new shares at €77.72 per share · in cash
- 06-12-2019 Capital increase of €200,000 · to €616,099.43 · 2,573 new shares at €77.73 per share · in cash
- 11-10-2019 Capital increase of €121,500 · to €337,599.43 · 1,563 new shares at €77.72 per share · in cash
- 11-10-2019 Converted to available equity
- 11-10-2019 Converted to available equity
- 10-12-2018 Capital increase of €82,499.43 · to €216,099.43 · 3,189 new shares at €25.87 per share · in cash
- 22-06-2018 Capital increase of €35,000 · to €53,600 · 18,818 new shares · in cash
Show 2 older capital entries
- 22-06-2018 Capital increase · to €59,318 · 3,074 new shares · in cash
- 22-06-2018 Capital increase of €74,282 · to €133,600 · no new shares · from reserves